Top Insulin Makers For U.S. All Commit To Significant Price Reductions

All three drug manufacturers that supply insulin to the United States have launched efforts to significantly reduce the cost of their products. Sanofi on Thursday (March 16) announced that in 2024, the price of its most widely prescribed insulin Lantus will be slashed by 78% , just after similar moves were announced by Eli Lilly and Novo Nordisk earlier this month. In addition to reducing the cost of Lantus, Sanofi will also implement its own $35 cap on out-of-pocket costs...